Ignite Creation Date:
2024-05-06 @ 2:46 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04418167
Status:
SUSPENDED
Last Update Posted:
2024-02-02
First Post:
2020-05-11
Brief Title:
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
Sponsor:
JS InnoPharm LLC
Organization:
JS InnoPharm LLC
Organization Data
Organization:
JS InnoPharm LLC
Class:
INDUSTRY
Study ID:
JSI-1187-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
JS InnoPharm LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None